Danielle Coppola

Summary

Affiliation: Johnson and Johnson Pharmaceutical Research and Development
Country: USA

Publications

  1. ncbi request reprint Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes
    Danielle Coppola
    Benefit Risk Management, a division of Johnson and Johnson Pharmaceutical Research and Development, LLC, Titusville, New Jersey 08560, USA
    Drug Saf 30:247-64. 2007

Detail Information

Publications1

  1. ncbi request reprint Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes
    Danielle Coppola
    Benefit Risk Management, a division of Johnson and Johnson Pharmaceutical Research and Development, LLC, Titusville, New Jersey 08560, USA
    Drug Saf 30:247-64. 2007
    ..A significant number of women of childbearing age have schizophrenia or other psychoses. This means that there is a considerable risk of in utero exposure to risperidone due to maternal use...